The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Phage Therapy of Pseudomonas aeruginosa Infection in a Mouse Burn Wound Model
Open accessAbstract
Mice compromised by a burn wound injury and subjected to a fatal infection with Pseudomonas aeruginosa were administered a single dose of a Pseudomonas aeruginosa phage cocktail consisting of three different P. aeruginosa phages by three different routes: the intramuscular (i.m.), subcutaneous (s.c.), or intraperitoneal (i.p.) route. The results of these studies indicated that a single dose of the P. aeruginosa phage cocktail could significantly decrease the mortality of thermally injured, P. aeruginosa -infected mice (from 6% survival without treatment to 22 to 87% survival with treatment) and that the route of administration was particularly important to the efficacy of the treatment, with the i.p. route providing the most significant (87%) protection. The pharmacokinetics of phage delivery to the blood, spleen, and liver suggested that the phages administered by the i.p. route were delivered at a higher dose, were delivered earlier, and were delivered for a more sustained period of time than the phages administered by the i.m. or s.c. route, which may explain the differences in the efficacies of these three different routes of administration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Church, D., Elsayed, S., Reid, O., Winston, B., & Lindsay, R. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.19.2.403-434.2006 · Cited by 1,876
Sulakvelidze, A., Alavidze, Z., & Morris, J. G. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.3.649-659.2001 · Cited by 1,566
Chromosomal genetics of Pseudomonas
Holloway, B. W., Krishnapillai, V., & Morgan, A. F. (1979) · Microbiological Reviews · doi:10.1128/mmbr.43.1.73-102.1979 · Cited by 761
Smith, H. W., & Huggins, M. B. (1982) · Microbiology · doi:10.1099/00221287-128-2-307 · Cited by 518
Long-circulating bacteriophage as antibacterial agents.
Merril, C. R., Biswas, B., Carlton, R., Jensen, N. C., Creed, G. J., Zullo, S., & Adhya, S. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.8.3188 · Cited by 512
Summers, W. C. (2001) · Annual Review of Microbiology · doi:10.1146/annurev.micro.55.1.437 · Cited by 474
Biswas, B., Adhya, S., Washart, P., Paul, B., Trostel, A. N., Powell, B., Carlton, R., & Merril, C. R. (2002) · Infection and Immunity · doi:10.1128/iai.70.1.204-210.2002 · Cited by 467
Smith, H. W., & Huggins, M. B. (1983) · Microbiology · doi:10.1099/00221287-129-8-2659 · Cited by 436
Bacteriophage therapy: a revitalized therapy against bacterial infectious diseases
Matsuzaki, S., Rashel, M., Uchiyama, J., Sakurai, S., Ujihara, T., Kuroda, M., Imai, S., Ikeuchi, M., Tani, T., Fujieda, M., et al. (2005) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-005-0408-9 · Cited by 409
Contribution of Quorum Sensing to the Virulence of Pseudomonas aeruginosa in Burn Wound Infections
Rumbaugh, K. P., Griswold, J. A., Iglewski, B. H., & Hamood, A. N. (1999) · Infection and Immunity · doi:10.1128/iai.67.11.5854-5862.1999 · Cited by 408 · cited 2×
“aeruginosa organisms in such an infection proliferate and spread systemically from skin to underlying tissues and that within 24 hpi as many as 10(4) PAO1 CFU per gram of tissue was detected in the liver and spleen (21).”
BackgroundBacteriophage Therapy To Reduce Campylobacter jejuni Colonization of Broiler Chickens
Loc Carrillo, C., Atterbury, R. J., El-Shibiny, A., Connerton, P. L., Dillon, E., Scott, A., & Connerton, I. F. (2005) · Applied and Environmental Microbiology · doi:10.1128/aem.71.11.6554-6563.2005 · Cited by 367
The Control of Experimental Escherichia coli Diarrhoea in Calves by Means of Bacteriophages
Smith, H. W., Huggins, M. B., & Shaw, K. M. (1987) · Microbiology · doi:10.1099/00221287-133-5-1111 · Cited by 365
Phage therapy: Facts and fiction
Skurnik, M., & Strauch, E. (2006) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2005.09.002 · Cited by 296
Barrow, P., Lovell, M., & Berchieri, A. (1998) · Clinical Diagnostic Laboratory Immunology · doi:10.1128/cdli.5.3.294-298.1998 · Cited by 293
Stieritz, D. D., & Holder, I. A. (1975) · Journal of Infectious Diseases · doi:10.1093/infdis/131.6.688 · Cited by 261
Twenty-five year review ofPseudomonas aeruginosa bacteremia in a burn center
McManus, A. T., Mason, A. D., McManus, W. F., & Pruitt, B. A. (1985) · European Journal of Clinical Microbiology · doi:10.1007/bf02013601 · Cited by 204
Experimental Bacteriophage Protection against Staphylococcus aureus Abscesses in a Rabbit Model
Wills, Q. F., Kerrigan, C., & Soothill, J. S. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.3.1220-1221.2005 · Cited by 180
Bacteriophage prevents destruction of skin grafts by Pseudomonas aeruginosa
Soothill, J. S. (1994) · Burns · doi:10.1016/0305-4179(94)90184-8 · Cited by 145
Phage therapy: a reappraisal of bacteriophages as antibiotics.
Inal, J. M. (2003) · PubMed · Cited by 130
Dynamics of success and failure in phage and antibiotic therapy in experimental infections
Bull, J. J., Levin, B. R., DeRouin, T., Walker, N., & Bloch, C. A. (2002) · BMC Microbiology · doi:10.1186/1471-2180-2-35 · Cited by 127
Pseudomonas AeruginosaInfections
Young, L. S., & Amstrong, D. (1972) · CRC Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408367209151698 · Cited by 100
Wang, J., Hu, B., Xu, M., Yan, Q., Liu, S., Zhu, X., Sun, Z., Tao, D., Ding, L., Reed, E., et al. (2006) · PubMed · Cited by 81
Mann, N. H. (2005) · PLoS Biology · doi:10.1371/journal.pbio.0030182 · Cited by 80
Hamood, A. N., Griswold, J., & Duhan, C. M. (1996) · Journal of Surgical Research · doi:10.1006/jsre.1996.0140 · Cited by 74
Danelishvili, L., Young, L. S., & Bermudez, L. E. (2006) · Microbial Drug Resistance · doi:10.1089/mdr.2006.12.1 · Cited by 74
Bacteriophage therapy: an alternative to conventional antibiotics.
Mathur, M., Vidhani, S., & Mehndiratta, P. L. (2003) · PubMed · Cited by 64
Capparelli, R., Ventimiglia, I., Roperto, S., Fenizia, D., & Iannelli, D. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01340.x · Cited by 58
Cited by
Phage Therapy: A Renewed Approach to Combat Antibiotic-Resistant Bacteria
Kortright, K. E., Chan, B. K., Koff, J. L., & Turner, P. E. (2019) · Cell Host & Microbe · doi:10.1016/j.chom.2019.01.014 · Cited by 1,212
Phage Cocktails and the Future of Phage Therapy
Chan, B. K., Abedon, S. T., & Loc-Carrillo, C. (2013) · Future Microbiology · doi:10.2217/fmb.13.47 · Cited by 914
Polymicrobial Interactions: Impact on Pathogenesis and Human Disease
Peters, B. M., Jabra-Rizk, M. A., O'May, G. A., Costerton, J. W., & Shirtliff, M. E. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.00013-11 · Cited by 712
Formulation, stabilisation and encapsulation of bacteriophage for phage therapy
Malik, D. J., Sokolov, I. J., Vinner, G. K., Mancuso, F., Cinquerrui, S., Vladisavljevic, G. T., Clokie, M. R. J., Garton, N. J., Stapley, A. G. F., & Kirpichnikova, A. (2017) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2017.05.014 · Cited by 594
Bacteriophage-encoded depolymerases: their diversity and biotechnological applications
Pires, D. P., Oliveira, H., Melo, L. D. R., Sillankorva, S., & Azeredo, J. (2016) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-015-7247-0 · Cited by 517
Metadata
- Authors
- McVay, C. S., Velásquez, M., & Fralick, J. A.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2007-06
- Volume
- 51
- Issue
- 6
- Pages
- 1934-1938
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2156495516
- Cited by
- 306
- References
- 27
- FWCI
- 9.67
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.